Andres Gomez/hematologia-uanl.com
Mar 15, 2025, 07:47
Poll on management of advanced Hodgkin Lymphoma by Andres Gomez
Andres Gomez, Associate Professor of Hematology at UANL, recently shared a poll on X regarding the optimal management of a young patient with advanced Hodgkin lymphoma and a bulky mediastinal mass:
“Young person with advanced Hodgkin lymphoma and bulky mediastinal mass. Received Nivo-AVDx6.
Interim PET Deauville 3, end-of-treatment PET Deauville 4 uptake in original bulky mass.”
The results of the poll are:
- RT consolidation – 38.5%
- Monitor – 34.4%
- Second line Rx – 20.7%
- Nivo maintenance – 6.3%.
More posts featuring Andres Gomez.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 8, 2025, 17:21
Aug 8, 2025, 17:21
Aug 8, 2025, 16:46
Aug 8, 2025, 16:41
Aug 8, 2025, 16:31
Aug 8, 2025, 16:11
Aug 8, 2025, 15:57
Aug 8, 2025, 15:54
Aug 8, 2025, 15:49